Interstitial fluid mirrors many biomarkers found in blood and has attracted growing interest as a target for painless diagnostics. Microneedles offer a way to access this fluid through the skin, but ...
Pulmovant, a Roivant Sciences subsidiary, has completed enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. The PHocus study is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results